Optimize your emergency room flow
suPARnostic® is a prognostic inflammatory biomarker that reflects the level of activation of the human immune system. A low suPAR level indicates a good prognosis and supports the decision to discharge the patient.
A high suPAR level indicates presence, progression and severity of disease, organ damage and risk of mortality, and supports further clinical attention.
This enables you to make your clinical decision based on prognostic evidence.
Read our latest news
Read the Journal “suPAR News” No. 3, 2020 – with lots of interesting articles and interviews regarding suPAR and COVID-19 from around the world! […]
Clinical Implementation of suPARnostic®TurbiLatex in routine use at The Cartagena University Hospital in Spain
suPARnostic® TurbiLatex will now be available for clinical decision making in the Emergency Department of Hospital General Universitario Santa Lucía in Cartagena, Spain. […]